344 related articles for article (PubMed ID: 35163550)
1. Role of miRNA-145, 148, and 185 and Stem Cells in Prostate Cancer.
Coradduzza D; Cruciani S; Arru C; Garroni G; Pashchenko A; Jedea M; Zappavigna S; Caraglia M; Amler E; Carru C; Maioli M
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163550
[TBL] [Abstract][Full Text] [Related]
2. Deregulation of miR-10b and miR-21 Correlate with Cancer Stem Cells Expansion through the Apoptotic Pathway in Prostate Cancer.
Shukla KK; Choudhary GR; Sankanagoudar S; Misra S; Vishnoi JR; Pareek P; Pilla KK; Pandey SN; Sharma P
Asian Pac J Cancer Prev; 2023 Jun; 24(6):2105-2119. PubMed ID: 37378942
[TBL] [Abstract][Full Text] [Related]
3. The potential of microRNAs as human prostate cancer biomarkers: A meta-analysis of related studies.
Song CJ; Chen H; Chen LZ; Ru GM; Guo JJ; Ding QN
J Cell Biochem; 2018 Mar; 119(3):2763-2786. PubMed ID: 29095529
[TBL] [Abstract][Full Text] [Related]
4. Characterization and Evidence of the miR-888 Cluster as a Novel Cancer Network in Prostate.
Hasegawa T; Glavich GJ; Pahuski M; Short A; Semmes OJ; Yang L; Galkin V; Drake R; Esquela-Kerscher A
Mol Cancer Res; 2018 Apr; 16(4):669-681. PubMed ID: 29330297
[TBL] [Abstract][Full Text] [Related]
5. Role of EZH2 in the growth of prostate cancer stem cells isolated from LNCaP cells.
Li K; Liu C; Zhou B; Bi L; Huang H; Lin T; Xu K
Int J Mol Sci; 2013 Jun; 14(6):11981-93. PubMed ID: 23739676
[TBL] [Abstract][Full Text] [Related]
6. Comparative analysis of epi-miRNA expression levels in local/locally advanced and metastatic prostate cancer patients.
Gurbuz V; Kiliccioglu I; Dikmen AU; Bilen CY; Sozen S; Konac E
Gene; 2020 Oct; 758():144963. PubMed ID: 32683077
[TBL] [Abstract][Full Text] [Related]
7. microRNA-1246 Is an Exosomal Biomarker for Aggressive Prostate Cancer.
Bhagirath D; Yang TL; Bucay N; Sekhon K; Majid S; Shahryari V; Dahiya R; Tanaka Y; Saini S
Cancer Res; 2018 Apr; 78(7):1833-1844. PubMed ID: 29437039
[TBL] [Abstract][Full Text] [Related]
8. miRNAs as novel biomarkers in the management of prostate cancer.
Filella X; Foj L
Clin Chem Lab Med; 2017 May; 55(5):715-736. PubMed ID: 26751899
[TBL] [Abstract][Full Text] [Related]
9. Identification of microRNA signature and potential pathway targets in prostate cancer.
Moustafa AA; Ziada M; Elshaikh A; Datta A; Kim H; Moroz K; Srivastav S; Thomas R; Silberstein JL; Moparty K; Salem FE; El-Habit OH; Abdel-Mageed AB
Exp Biol Med (Maywood); 2017 Mar; 242(5):536-546. PubMed ID: 27903835
[TBL] [Abstract][Full Text] [Related]
10. miR-25 Modulates Invasiveness and Dissemination of Human Prostate Cancer Cells via Regulation of αv- and α6-Integrin Expression.
Zoni E; van der Horst G; van de Merbel AF; Chen L; Rane JK; Pelger RC; Collins AT; Visakorpi T; Snaar-Jagalska BE; Maitland NJ; van der Pluijm G
Cancer Res; 2015 Jun; 75(11):2326-36. PubMed ID: 25858144
[TBL] [Abstract][Full Text] [Related]
11. Recent scenario of microRNA as diagnostic and prognostic biomarkers of prostate cancer.
Shukla KK; Misra S; Pareek P; Mishra V; Singhal B; Sharma P
Urol Oncol; 2017 Mar; 35(3):92-101. PubMed ID: 27890424
[TBL] [Abstract][Full Text] [Related]
12. Loss of RBMS1 as a regulatory target of miR-106b influences cell growth, gap closing and colony forming in prostate carcinoma.
Dankert JT; Wiesehöfer M; Wach S; Czyrnik ED; Wennemuth G
Sci Rep; 2020 Oct; 10(1):18022. PubMed ID: 33093529
[TBL] [Abstract][Full Text] [Related]
13. microRNA expression in tumour tissue and plasma in patients with newly diagnosed metastatic prostate cancer.
Zedan AH; Hansen TF; Assenholt J; Pleckaitis M; Madsen JS; Osther PJS
Tumour Biol; 2018 May; 40(5):1010428318775864. PubMed ID: 29775158
[TBL] [Abstract][Full Text] [Related]
14. In Silico Identification of Human miR 3654 and its Targets Revealed its Involvement in Prostate Cancer Progression.
Saravanan S; Islam VI; Thirugnanasambantham K; Sekar D
Microrna; 2016; 5(2):140-145. PubMed ID: 27297584
[TBL] [Abstract][Full Text] [Related]
15. Identification and Functional Validation of Reciprocal microRNA-mRNA Pairings in African American Prostate Cancer Disparities.
Wang BD; Ceniccola K; Yang Q; Andrawis R; Patel V; Ji Y; Rhim J; Olender J; Popratiloff A; Latham P; Lai Y; Patierno SR; Lee NH
Clin Cancer Res; 2015 Nov; 21(21):4970-84. PubMed ID: 26089375
[TBL] [Abstract][Full Text] [Related]
16. Loss of miR-100 enhances migration, invasion, epithelial-mesenchymal transition and stemness properties in prostate cancer cells through targeting Argonaute 2.
Wang M; Ren D; Guo W; Wang Z; Huang S; Du H; Song L; Peng X
Int J Oncol; 2014 Jul; 45(1):362-72. PubMed ID: 24805183
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-7 inhibits the stemness of prostate cancer stem-like cells and tumorigenesis by repressing KLF4/PI3K/Akt/p21 pathway.
Chang YL; Zhou PJ; Wei L; Li W; Ji Z; Fang YX; Gao WQ
Oncotarget; 2015 Sep; 6(27):24017-31. PubMed ID: 26172296
[TBL] [Abstract][Full Text] [Related]
18. miRNA-mRNA correlation-network modules in human prostate cancer and the differences between primary and metastatic tumor subtypes.
Zhang W; Edwards A; Fan W; Flemington EK; Zhang K
PLoS One; 2012; 7(6):e40130. PubMed ID: 22768240
[TBL] [Abstract][Full Text] [Related]
19. Change in expression of miR-let7c, miR-100, and miR-218 from high grade localized prostate cancer to metastasis.
Leite KR; Sousa-Canavez JM; Reis ST; Tomiyama AH; Camara-Lopes LH; Sañudo A; Antunes AA; Srougi M
Urol Oncol; 2011; 29(3):265-9. PubMed ID: 19372056
[TBL] [Abstract][Full Text] [Related]
20. Downregulated expression of miRNA-149 promotes apoptosis in side population cells sorted from the TSU prostate cancer cell line.
Chen Y; Zhao J; Luo Y; Wang Y; Jiang Y
Oncol Rep; 2016 Nov; 36(5):2587-2600. PubMed ID: 27573045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
